Literature DB >> 9003087

Inhibition of contractile responses of human myometrium and intramyometrial arteries by potassium channel openers.

A Kostrzewska1, T Laudański, S Batra.   

Abstract

OBJECTIVES: The effects of cromakalim and pinacidil on the contractile activity of the isolated human myometrium and intramyometrial arteries were studied. MATERIAL AND
METHOD: Myometrial strips and pieces of uterine arteries were obtained from women undergoing hysterectomy. Contractions were recorded under isometric conditions.
RESULTS: Both compounds (10(-9) M-5 x 10(-6) M) inhibited the spontaneous activity of the myometrium and vasopressin induced contractions of myometrium and intramyometrial arteries. There was no statistically significant difference in the responses of both tissues to cromakalim or pinacidil. Both compounds reduced responses of myometrium and intramyometrial arteries to low concentration of K+ (< 40 mM) but did not decrease contractions induced by 40 mM and 80 mM.
CONCLUSION: The combined effect on the uterus and intrauterine vasculature would suggest a potential in the use of cromakalim or pinacidil for the treatment of dysmenorrhea.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003087     DOI: 10.3109/00016349609055022

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

1.  Regulation of myometrial contraction by ATP-sensitive potassium (KATP) channel via activation of SUR2B and Kir 6.2 in mouse.

Authors:  Seung Hwa Hong; Kyu-Sang Kyeong; Chan Hyung Kim; Young Chul Kim; Woong Choi; Ra Young Yoo; Hun Sik Kim; Yeon Jin Park; Il Woon Ji; Eun-Hwan Jeong; Hak Soon Kim; Wen-Xie Xu; Sang Jin Lee
Journal:  J Vet Med Sci       Date:  2016-04-18       Impact factor: 1.267

2.  Apamin inhibits NO-induced relaxation of the spontaneous contractile activity of the myometrium from non-pregnant women.

Authors:  Beata Modzelewska; Anna Kostrzewska; Marek Sipowicz; Tomasz Kleszczewski; Satish Batra
Journal:  Reprod Biol Endocrinol       Date:  2003-02-05       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.